Pharmafile Logo

dual tasking

- PMLiVE

Regeneron’s COVID-19 antibody cocktail reduces viral load and alleviates symptoms

Investigational treatment also helped patients recover faster

- PMLiVE

GSK chief exec ‘optimistic’ COVID-19 vaccine could be available next year

GSK is currently partnering with Sanofi on a COVID-19 vaccine project

- PMLiVE

The concordance conundrum: understanding the complexities of behaviour change

Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved.

Page & Page Health

- PMLiVE

Moderna’s COVID-19 vaccine generates strong immune response in older adults

New data builds on initial data read-out announced in August

- PMLiVE

The concordance conundrum: creating space for open dialogue

Growing numbers of patients want a partnership model with their HCP, whereby both parties are equally involved in the decision-making process. This model has been linked with an increase in...

Page & Page Health

- PMLiVE

Switzerland: a life sciences hub

Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country

- PMLiVE

Inovio hit with FDA hold on COVID-19 vaccine trial

Trial placed on hold after FDA raises questions over delivery device

- PMLiVE

Researchers call on Pfizer to delay COVID-19 vaccine application

Reports that the company could seek regulatory approval in October have raised safety concerns

- PMLiVE

FDA sets November date for expert panel review of Biogen’s aducanumab

Advisory committee will review biologics license application for controversial therapy

- PMLiVE

Responding to dynamic shifts in value communications

OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies.

OPEN Health

- PMLiVE

Taking a holistic approach to patient care

The importance of recognising each patient as an individual

- PMLiVE

Diversity and inclusion

It may not be something we can change overnight, but it is certainly something we need to start to address now

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links